Summary 5-Methoxy-N,N-diisopropyltryptamine (often referred to as 5-MeO-DiPT, colloquially known as foxy methoxy or simply foxy) is a member of the psychedelic tryptamine class and represents the methoxy derivative of diisopropyltryptamine (DiPT). Identifiers IUPAC name CAS Number 4021-34-5 PubChem CID 151182 DrugBank DB01441 ChemSpider 133247 UNII 12D06G8W8E ChEBI CHEBI:48282 CompTox Dashboard (EPA) DTXSID00193209 Chemical and physical …
Summary 5-MeO-DET, also known as 5-methoxy-N,N-diethyltryptamine, is a hallucinogenic tryptamine compound. Identifiers CAS Number 2454-70-8 PubChem CID 417608 ChemSpider 369669 UNII LM6R54JKYE ChEMBL ChEMBL342986 CompTox Dashboard (EPA) DTXSID30329130 Chemical and physical data Formula C15H22N2O Molar mass 246.354 g·mol−1 Pharmacology 5-MeO-DET demonstrates an inhibition of serotonin reuptake with an IC50 value of 2.4 μM and activates 5-HT2A …
Summary 5-MeO-DALT, also known as N,N-di allyl-5-methoxy tryptamine, is a psychedelic tryptamine compound that was initially synthesized by Alexander Shulgin. Identifiers IUPAC name CAS Number 928822-98-4 PubChem CID 50878551 ChemSpider 21106245 UNII V25VK0QTAA ChEMBL ChEMBL2391541 CompTox Dashboard (EPA) DTXSID30239169 Chemical and physical data Formula C17H22N2O Molar mass 270.376 g·mol−1 Chemistry The chemical is formally known as …
Summary 5-Chloro-N, N-dimethyltryptamine, commonly referred to as 5-chloro-DMT, belongs to the family of tryptamine derivatives, sharing a kinship with substances like 5-bromo-DMT and 5-fluoro-DMT. In its function, it serves as an agonist of serotonin receptors and, in animal studies, has predominantly exhibited sedative effects. Notably, it has been marketed and distributed as a designer drug. …
Summary 5-Bromo-DMT, scientifically known as 5-Bromo-N, N-dimethyltryptamine, is a psychedelic compound in the class of brominated indole alkaloids. This particular alkaloid can be found in sponges like Smenospongia aurea and Smenospongia echina, as well as in Verongula rigida, where it constitutes a minute fraction of the dry weight (approximately 0.00142%). It is found alongside 5,6-Dibromo-DMT …
Summary 4-MeO-MiPT, also known as 4-methoxy-N-methyl-N-isopropyltryptamine, is a relatively obscure psychedelic substance. It represents the 4-methoxy counterpart to MiPT. This compound was initially synthesized by Alexander Shulgin and is documented in his book “TiHKAL” (Tryptamines I Have Known And Loved).In human trials conducted by Shulgin, an effective dose of 20-30 mg (equivalent to 0.4 mg …
Summary 4-HO-EPT, also known as 4-hydroxy-N-ethyl-N-propyltryptamine, is an infrequently encountered chemical compound in the tryptamine class. It shares a structural similarity with psilocin (4-HO-DMT). Identifiers CAS Number 2595431-59-5 [PubChem] 3D model (JSmol) Interactive image PubChemCID 138454310 UNII Y3J8M5UX6G SMILES Properties Chemical formula C15H22N2O Molar mass 246.354 g·mol−1 Legality United Kingdom: The use of 4-HO-EPT is prohibited in the …
Summary 4-HO-MPT, also referred to as meprocin, is a psychedelic substance classified within the tryptamine family of compounds. It serves as a higher homologue of psilocin, a naturally occurring substituted tryptamine, and is specifically the 4-hydroxyl analog of MPT. Identifiers CAS Number 763035-03-6 (Free base) 77872-42-5 (Hydrochloride) 3D model (JSmol) Interactive image ChemSpider 10513074 PubChemCID 21786584 …
Summary 4-HO-McPT, 4-hydroxy-N-methyl-N-cyclopropyltryptamine, is a derivative of tryptamine known for its psychedelic properties. It exerts serotonergic effects, contributing to its psychoactive nature. Although it has been available as a designer drug in the market since approximately 2016, forensic laboratories didn’t definitively identify it until 2018. Notably, 4-HO-McPT is classified as illegal in Finland. Identifiers IUPAC …
Summary 4-HO-MPMI, alternatively referred to as 4-Hydroxy-N-methyl-(α, N-trimethylene)-tryptamine or lucigenol, belongs to the category of tryptamine derivatives and possesses psychedelic properties. Originating in the late 1990s, it was developed under the leadership of David Nichols at Purdue University. This compound exhibits hallucinogenic effects in animal trials, displaying potency akin to the amphetamine-derived psychedelic DOI. Notably, …
